Media Center

Events

2017
  • June - 2017 BIO International Convention. San Diego, CA (USA)
  • March - BioEurope. Barcelona (Catalonia - Spain)
  • March - 10th Annual European Life Sciences CEO Forum & Exhibition. Zurich (Switzerland)
2016
  • October - BioEurope. Cologne (Germany)
  • October - CPhI. Barcelona (Catalonia, Spain)
  • June - BIO international convention. San Francisco, CA (USA)
  • September - BioSpain. Bilbao (Spain)
  • September - BioJapan (Japan)
2015
  • November - AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Boston, MA (USA)
  • September - ESMO: European Society for Medical Oncology. Vienna (Austra)
  • May - IATI Biomed. Tel Aviv (Israel)
  • May - Biotrinity. London (UK)
  • April - Anglonordic Life Science Conference. XX (Spain)
  • February - BIO CEO & Investor Conference. New York, NY (USA)
2013
  • April - BIO International Convention. Chicago, IL (USA)
  • March - BioEurope Spring. Barcelona (Catalonia, Spain)
  • March - Company presentation at 6th Annual European Life Science CEO Forum for Partnering & Investing. Zurich (Switzerland)
  • January - Company presentation at Biotech Showcase at JP Morgan Healthcare Conference. San Francisco, CA (USA)
2012
  • September - Poster session at the 8th International Translational Oncology Symposium. Barcelona
  • July - Poster session at the meeting of the European Association for Cancer Research (EACR). Barcelona (Catalonia, Spain)
  • June - Booth at BIO International Convention. Boston, MA (USA)
  • June - Company presentation at the International Cancer Cluster Showcase. Boston, MA (USA)
  • April - Poster session at the meeting of the American Association for Cancer Research (AACR). Chicago, IL (USA)
  • March - Company presentation at 5th Annual European Life Science CEO Forum for Partnering & Investing. Zurich (Switzerland)
2011
  • November - Company presentation at NYC Landmark Venture Forum - Investing for Cures. New York, NY (USA)
  • November - Company presentation at Foro Neotec (CDTI). Logrono (Spain)
  • September - Company presentation at MassBio’s Global Gateway. Boston, MA (USA)
  • September - Company presentation at BioPharm America. Boston, MA (USA)
  • May - Company presentation at Oncology Forum Farmaindustria. Madrid (Spain)
  • June - BIO International Convention. Washington, DC (USA)
  • May - 7th International Translational Oncology Symposium. Barcelona (Catalonia, Spain)
  • April - BioTrinity. Newbury (United Kingdom)
  • January - Company presentation at 4th Annual European Life Science CEO Forum for Partnering & Investing. Zurich (Switzerland)
2010
  • November - BioEurope. Munich (Germany)
  • November - Company presentation at European Venture Capital Contest Summit. Düsseldorf (Germany)
  • October - Company presentation at European Venture Capital Contest Semi-Final. Pamplona (Spain)
  • September - Company presentation at BioSpain. Pamplona (Spain)
  • August - Company presentation at European Venture Capital Contest Semi-Final. Aarhus (Denmark)
  • June - HiT Barcelona World Innovation Summit. Barcelona (Catalonia, Spain)
  • March - BioEurope Spring. Barcelona (Catalonia, Spain)

LATEST NEWS

07.03.2017

News

Ability Pharma sponsors the 37th National Meeting of the Spanish Society of Pharmacology + info
20.02.2017

News

Ability Pharmaceuticals launches a new updated website with a fresh design + info
15.12.2016

News

Ability Pharmaceuticals Announces FDA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer + info
22.11.2016

News

Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First Line Therapy in Patients with Endometrial or Squamous Lung Cancer Patients + info
11.05.2016

News

Ability Pharmaceuticals Enters into a Licensing Agreement with SciClone Pharmaceuticals for the Novel Anticancer Agent ABTL0812 for the China Market. + info
07.04.2015

News

Ability Pharmaceuticals Receives Positive Opinion from EMA for Orphan Drug Status of ABTL0812 in Pediatric Cancer Neuroblastoma. + info
14.02.2014

News

Ability Pharmaceuticals to Present at the 7th Annual European Life Sciences CEO Forum in Zurich, March 4-5, 2014. + info
05.02.2014

News

ABILITY PHARMACEUTICALS Initiates Clinical Trial with its Dual mTORC1/C2 Inhibitor ABTL0812 in Patients with Lung and Pancreatic Cancer + info
19.02.2013

News

Ability Pharmaceuticals to Present at the 6th Annual European Life Sciences CEO Forum in Zurich, March 5-6, 2013. + info
© 2012 Ability Pharma / All Rights Reserved / Legal Notice / Privacy Police
Credits